Cyril Montagne

This inventor holds 9 USPTO granted patents and 2 published patent applications, plus 6 CIPO patents and 8 EPO patents. Top assignees: Merck Serono S. a., Ares Trading S.a.. Active years: 2012-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cyril Montagne. Retrieved from https://idiyas.com/inventor/cyril-montagne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 2)

% Patents Active = 22.2

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 8 (Patent Applications = 8)

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 8(Granted Patents)

Company Filing History:

Years Active: 2012-2016

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9403835 - Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators (2016-08-02),

2. 8889668 - Oxadiazole diaryl compounds (2014-11-18),

3. 8815919 - Oxadiazole derivatives (2014-08-26),

4. 8802704 - Oxadiazole derivatives (2014-08-12),

5. 8741923 - Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis (2014-06-03),

6. 8614215 - Quinoxaline inhibitors of phosphoinositide-3-kinases (PI3Ks) (2013-12-24),

7. 8609666 - 2-morpholino-pyrido[3,2-D]pyrimidines (2013-12-17),

8. 8404676 - Oxadiazole diaryl compounds (2013-03-26),

9. 8202865 - Oxadiazole derivatives (2012-06-19),

Title: The Innovative Contributions of Cyril Montagne

Introduction

Cyril Montagne is a notable inventor based in Saint-Genis-Pouilly, France. He has made significant contributions to the field of medicinal chemistry, holding a total of nine patents. His work primarily focuses on developing compounds that serve as therapeutic agents for various diseases.

Latest Patents

Among his latest patents is the invention titled "Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators." This invention provides compounds that act as M1 receptor positive allosteric modulators, which are crucial for treating diseases mediated by the muscarinic M1 mediator. Another significant patent is related to "Oxadiazole diaryl compounds," which are useful in treating autoimmune disorders, including multiple sclerosis. These compounds are defined by specific formulas that detail their chemical structure and potential applications.

Career Highlights

Cyril Montagne has worked with prominent companies in the pharmaceutical industry, including Merck Serono S.A. and Ares Trading S.A. His experience in these organizations has allowed him to contribute to the development of innovative therapeutic solutions.

Collaborations

Throughout his career, Montagne has collaborated with esteemed colleagues, including Anna Quattropani and Wolfgang Sauer. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Cyril Montagne's contributions to medicinal chemistry through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to impact the development of treatments for various medical conditions.

Profile summary based on public USPTO records.